%0 Journal Article
%T Adipokines, Oxidized Low-Density Lipoprotein, and C-Reactive Protein Levels in Lean, Overweight, and Obese Portuguese Patients with Type 2 Diabetes
%A Maria Jo£¿o Neuparth
%A Jorge Brand£¿o Proen£¿a
%A Alice Santos-Silva
%A Susana Coimbra
%J ISRN Obesity
%D 2013
%R 10.1155/2013/142097
%X Aim. Our aim was to study how different BMI scores may influence the levels of inflammation, oxidative stress, adipogenesis, glucose, and lipid metabolism, in lean, overweight, and obese Portuguese patients with type 2 diabetes mellitus (T2DM). Methods. We studied 28 lean, 38 overweight, and 17 obese patients with T2DM and 20 controls (gender and age matched). The circulating levels of oxLDL, CRP, and some adipokines¡ªadiponectin, leptin, and chemerin¡ªand the lipid profile were evaluated. Results. Obese patients presented significantly lower levels of adiponectin and higher leptin, oxLDL, and chemerin levels, as compared to the overweight, lean, and control groups. Overweight, compared to lean and control, subjects showed significantly lower adiponectin and higher leptin and chemerin levels; oxLDL values were significantly higher in overweight than in lean patients. Lean patients presented significantly higher chemerin values than the control. Obese patients presented significantly higher CRP values, as compared to lean patients and the control group. Obese and overweight patients presented significantly higher triglycerides values than lean patients. Except for CRP, all the observed significant changes between control and patients remained significant after statistical adjustment for the body mass index (BMI). Conclusion. The levels of leptin, adiponectin, oxLDL, CRP, and triglycerides in patients with T2DM seem to be more associated with obesity and less with diabetes. Chemerin levels were raised in lean, overweight, and obese patients, suggesting that, independently of BMI, an adipocyte dysfunction occurs. Moreover, chemerin may provide an important early biomarker of adipocyte dysfunction and a link between obesity and type 2 diabetes mellitus. 1. Introduction Type 2 diabetes mellitus (T2DM) and obesity are independent global health problems, but an association between the two is known to exist. Patients with diabetes often present overweight and obesity [1]. Obesity prevalence is increasing significantly and obesity associates with the risk of T2DM and cardiovascular disease (CVD) events [2, 3]. The adipose tissue is a metabolically active organ, secreting numerous adipokines and proinflammatory cytokines, known to be important in the inflammatory and atherosclerotic processes [4]. Adiponectin has an anti-inflammatory activity and protects against metabolic and cardiovascular diseases [5]. Leptin is another adipokine and the reduction in its activity leads to severe insulin resistance and vascular dysfunction [6]. Chemerin is a novel adipokine that
%U http://www.hindawi.com/journals/isrn.obesity/2013/142097/